Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for preparation of sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine

A sulfation and compound technology, applied in chemical instruments and methods, sulfonic acid preparation, biological testing, etc., can solve problems such as extremely large volume and not necessarily recovery

Active Publication Date: 2018-03-27
BRACCO IMAGINIG SPA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, treatment with levothyroxine also exhibits some disadvantages related to the fact that while plasma thyroid is restored, tissue thyroid is not necessarily restored.
[0013] However, to date, none of the prior art methods can be scaled up for the gram yield of the final product in pure form, mainly because the reported purification steps require extremely large volumes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparation of sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine
  • Process for preparation of sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine
  • Process for preparation of sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0096] T2 is preferably prepared as described.

[0097] The addition of the iodinating agent is carried out at preferably below 25°C in the presence of an aqueous solvent, preferably water.

[0098] Preferably, the iodinating agent is present in a molar ratio of 0.9 to 1.1 mol / mol of compound III (T2).

[0099] After iodination, T3 is isolated as the sodium salt, preferably by filtration, and then converted to the acid form by resuspension in water and acidification with acid, preferably acetic acid or sulfuric acid.

[0100] The acid form is preferably isolated by filtration, resuspended in water to remove salts and filtered.

[0101] T3 as a wet solid was suspended in N,N-dimethylacetamide, the suspension was dehydrated and subjected to sulfation.

[0102] According to a preferred variant, the molar ratio between CSA and T3 is greater than 4, preferably from 4.5 to 10, even more preferably from 7 to 9. Even more preferably, 7.5 to 8.5 mol of CSA / mol of T3. The concentrat...

Embodiment 1

[0141] Example 1. In DMAC T 3 Preparation of S

[0142] The total amount of raw materials is expressed relative to 100 g of T3.

[0143] Under nitrogen atmosphere, 3,5-diiodo-O-(4-hydroxy-3-iodophenyl)-L-tyrosine (100 g; 0.154 mol) was suspended in DMAC (2.0 L) and stirred vigorously to avoid precipitation of solids. After cooling to -5°C, CSA (142.2 g; 1.229 mol) was added dropwise within 40 minutes while maintaining the temperature between -5 and 5°C. At the end of the addition, cooling was stopped and the reaction mixture was left under stirring for about 4 h. The reaction mixture was added dropwise to a stirred aqueous solution of sodium bicarbonate (335.5 g; 3.994 mol aqueous solution, 4.5 L) over 1.5 h. At the end of the addition, a crystalline solid precipitate was observed over time from the solution thus obtained as a mixture of inorganic salts. Filter out this solid, then in Amberlite TM XAD TM 1600, the resulting solution was purified by elution with water / a...

Embodiment 2

[0144] Example 2. Preparation of T from T2 (Levoditi) 3 S

[0145] The schematic diagram of the reaction is as follows:

[0146]

[0147] All raw material quantities are expressed for 1 kg of Levoditi.

[0148] Iodine (about 0.48 kg, source: SQM), NaI (about 0.65 kg, source: Ajay-SQM) and water were charged into the reactor at 18-22°C and stirred until completely dissolved. The resulting iodinated mixture was continuously stirred at room temperature until use.

[0149] Levoditi obtained from L-tyrosine according to the method described in Chalmers, J.R. et al. A. J. Chem. Soc. 1949, 3424-3433), NaI (approx. 0.32 kg) and water were charged to another reactor, And 70% monoethylamine was added.

[0150] The iodination mixture was added to the reaction mixture.

[0151] The resulting suspension was stirred at 18-22 °C for at least 6 h, then cooled to 0 °C within 1 h, stirred for 3-4 h and filtered. The filter cake was washed with water.

[0152] The wet solid was suspend...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a process for the preparation of the mono sodium salt of the derivative 3,5-diiodo-O-[3-iodo-4-(sulphooxy)phenyl]-L-tyrosine (T3S) by starting from the corresponding phenoliccompound, in the presence of chlorosulfonic acid and dimethylacetamide as a solvent. The so obtained T3S compound may conveniently be isolated in a pure form as a solid in good yields. The invention further relates to the process for T3S preparation, wherein the starting reagent is T2 and further comprising the formulation of such compound in tablets. Furthermore, the invention discloses non-radioactive immunoassays based on T3S derivatives.

Description

[0001] This application is Chinese Patent Application No. 201280023319.5 (PCT / EP2012 / 056274), the application date is April 5, 2012, and the title of the invention is "for the preparation of 3,5-diiodo-O-[3-iodophenyl]-L -A divisional application for a method for sulfated derivatives of tyrosine". field of invention [0002] The field of the invention relates to processes for the preparation of sulfated derivatives of thyroid hormones or salts thereof. Background of the invention [0003] Thyroid hormone Triiodothyronine (3,5-diiodo-O-[3-iodophenyl]-L-tyrosine or T3) is the most metabolically active thyroid hormone. Like thyroxine (T4), it is produced physiologically by the thyroid gland and stored together with its thyroglobulin form, a glycoprotein precursor. On average, a thyroglobulin molecule contains three or four T4 residues and at most one T3 residue. TSH production activates proteolysis of thyroglobulin by the enzymes cathepsins D, B, and L, releasing the thyroid ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C303/32C07C309/42
CPCC07C303/32C07C309/42C07C303/24C07C303/44G01N33/78A61P43/00A61P5/14C07C305/24A61K31/198C07C303/08
Inventor P·L·阿内力M·阿尔格赛V·波尔L·卡瓦雷力L·嘉礼姆波蒂S·加泽多L·拉图阿达F·麦萨诺G·利沃尔塔F·韦拉
Owner BRACCO IMAGINIG SPA